Folgen
Prateek Pathak
Titel
Zitiert von
Zitiert von
Jahr
JNK pathway signaling: a novel and smarter therapeutic target for various biological diseases
A Kumar, UK Singh, SG Kini, V Garg, S Agrawal, PK Tomar, P Pathak, ...
Future medicinal chemistry 7 (15), 2065-2086, 2015
2192015
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
A Kumar, AK Singh, H Singh, V Vijayan, D Kumar, J Naik, S Thareja, ...
Pharmaceuticals 16 (2), 299, 2023
1442023
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
S Ankit Kumar, K Adarsh, S Harshwardhan, S Pankaj, P Harshali, ...
Pharmaceuticals 15 (9), 1071, 2022
106*2022
Metal Complexes in cancer treatment: Journey so far
A Kumar Singh, A Kumar, H Singh, P Sonawane, P Pathak, M Grishina, ...
Chemistry & Biodiversity 20 (4), e202300061, 2023
442023
Evaluation of Polyherbal Ayurvedic Formulation ‘Peedantak Vati’ for Antiinflammatory and Analgesic Properties
VRA Acharya Balkrishna, Ravikant Ranjan, Sachin S Sakat, Vinay K. Sharma ...
Journal of Ethnopharmacology 235, 361-374, 2019
372019
Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies
JP Yadav, AK Singh, M Grishina, P Pathak, A Verma, V Kumar, P Kumar, ...
Inflammopharmacology 32 (1), 149-228, 2024
302024
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking
J Novak, H Rimac, S Kandagalla, P Pathak, V Naumovich, M Grishina, ...
Journal of Biomolecular Structure and Dynamics 40 (19), 9347-9360, 2022
262022
Quinazoline clubbed 1, 3, 5-triazine derivatives as VEGFR2 kinase inhibitors: Design, synthesis, docking, in vitro cytotoxicity and in ovo antiangiogenic activity
P Pathak, PK Shukla, V Kumar, A Kumar, A Verma
Inflammopharmacology 26, 1441-1453, 2018
262018
1, 2, 4-Triazole Scafolds: Recent Advances and Pharmacological Applications
APP Anjali Thakur, Puspraj S. Gupta, Parjanya kumar shukla
Int. J. Curr. Res. Aca. Rev 4 (2), 277-296, 2016
262016
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF V600E inhibitors
AK Singh, J Novak, A Kumar, H Singh, S Thareja, P Pathak, M Grishina, ...
RSC advances 12 (46), 30181-30200, 2022
222022
Quinazoline based 1, 3, 5‐triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study
P Pathak, V Naumovich, M Grishina, PK Shukla, A Verma, V Potemkin
Archiv der Pharmazie 352 (9), 1900053, 2019
212019
Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE2)
NP Neupane, AK Karn, IH Mukeri, P Pathak, P Kumar, S Singh, IA Qureshi, ...
Biocatalysis and Agricultural Biotechnology 32, 101924, 2021
202021
1, 2, 4‐Triazole‐conjugated 1, 3, 4‐thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan‐induced inflammation by lessening proinflammatory mediators
P Pathak, PK Shukla, V Naumovich, M Grishina, A Verma, V Potemkin
Archiv der Pharmazie 353 (1), 1900233, 2020
182020
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives
T Ram, AK Singh, A Kumar, H Singh, P Pathak, M Grishina, H Khalilullah, ...
RSC Medicinal Chemistry, 2023
172023
Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study
AK Mandal, S Paudel, A Pandey, P Yadav, P Pathak, M Grishina, ...
Antioxidants 11 (11), 2204, 2022
172022
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022
AK Singh, P Sonawane, A Kumar, H Singh, V Naumovich, P Pathak, ...
ACS omega 8 (31), 27819-27844, 2023
162023
Hybrid Quinazoline 1, 3, 5‐Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study
P Pathak, H Rimac, M Grishina, A Verma, V Potemkin
ChemMedChem 16 (5), 822-838, 2021
152021
Green synthesis of silver nanoformulation of Scindapsus officinalis as potent anticancer and predicted anticovid alternative: Exploration via experimental and computation methods
AV Manish Pathak, PrateekPathak, Habibullah Khalilullah, MariaGrishina ...
Biocatalysis and Agricultural Biotechnology 35 (10), 102072, 2021
152021
A triterpene glochidon from Phyllanthus debilis: Isolation, computational studies, and antidiabetic activity evaluation
A Verma, P Pathak, H Rimac, H Khalilullah, V Kumar, M Grishina, ...
Biocatalysis and Agricultural Biotechnology 36, 102138, 2021
142021
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1, 2, 4‐triazole scaffolds
P Pathak, J Novak, PK Shukla, M Grishina, V Potemkin, A Verma
Archiv der Pharmazie 354 (6), 2000473, 2021
142021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20